- Poster presentation
- Open Access
Effect of cyproheptadine on combat related PTSD nightmares
© The Author(s) 2006
- Published: 28 February 2006
- Public Health
- Patient Study
- Stress Disorder
- Open Trial
Recent studies have shown the role serotonergic system in post-traumatic stress disorder. Trazodone and Nefazodone (5H2 antagonist) amilorated PTSD nightmares but the receptors are mixed. This study promoted an open trial of cyporoheptadine for Iran versus Iraq combat related PTSD patients nightmares.
25 patients studies in 8 week, before after trial of cyproheptadine, the participant were male and chronic PTSD patients with combat related nightmares.
5 patients were excluded from the study because of side effects including dizziness and somnolence. 20 patients completed the study. Average nightmare severity decreased from 6.85 to 5.05 which was statistically signifcant (p < 0.01).
Cyproheptadine may be effective in PTSD nightmare treatment.